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The contribution of individuals with subclinical infection to the transmission and endemicity
of cutaneous leishmaniasis (CL) is unknown. Immunological evidence of exposure to Leish-
mania in residents of endemic areas has been the basis for defining the human population
with asymptomatic infection. However, parasitological confirmation of subclinical infection
is lacking.
Methods
We investigated the presence and viability of Leishmania in blood and non-invasive muco-
sal tissue samples from individuals with immunological evidence of subclinical infection in
endemic areas for CL caused by Leishmania (Viannia) in Colombia. Detection of Leishmania
kDNA was conducted by PCR-Southern Blot, and parasite viability was confirmed by ampli-
fication of parasite 7SLRNA gene transcripts. A molecular tool for genetic diversity analysis
of parasite populations causing persistent subclinical infection based on PCR amplification
and sequence analysis of an 82bp region between kDNA conserved blocks 1 and 2 was
developed.
Principal Findings
Persistent Leishmania infection was demonstrated in 40% (46 of 114) of leishmanin skin
test (LST) positive individuals without active disease; parasite viability was established in
59% of these (27 of 46; 24% of total). Parasite burden quantified from circulating blood
monocytes, nasal, conjunctival or tonsil mucosal swab samples was comparable, and ran-
ged between 0.2 to 22 parasites per reaction. kDNA sequences were obtained from sam-
ples from 2 individuals with asymptomatic infection and from 26 with history of CL, allowing
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Conclusions
Our results provide parasitological confirmation of persistent infection among residents of
endemic areas of L. (Viannia) transmission who have experienced asymptomatic infection
or recovered from CL, revealing a reservoir of infection that potentially contributes to the
endemicity and transmission of disease. kDNA genotyping establishes proof-of-principle of
the feasibility of genetic diversity analysis in previously inaccessible and unexplored para-
site populations in subclinically infected individuals.
Author Summary
A variable and often high proportion of individuals residing in areas where cutaneous
leishmaniasis is endemic are exposed to Leishmania parasites, yet do not develop symp-
toms of disease. The role of this asymptomatic population in the transmission of disease is
unknown and could interfere with the effectiveness of community or population-based
control measures. Exposure to Leishmania is indirectly assessed by immunological tests;
however, immunological evidence does not discriminate between historical exposure to
the parasite and actual presence of parasites without causing clinical manifestations.
We sought to determine whether viable Leishmania are present in individuals with
immunological evidence of asymptomatic infection. Our results showed that at least 24%
of individuals having immunological evidence of subclinical or asymptomatic infection
harboured live Leishmania. These individuals may be at risk of activation of disease, or
could represent an unperceived reservoir of parasites for vector-borne transmission. Char-
acterization of Leishmania causing asymptomatic infection has not been possible due to
technical limits of detection of parasites in low grade infections. We developed a molecular
method that allows genotypic analysis of parasites involved in subclinical infection and
potentially provides a means to assess their involvement in transmission.
Introduction
Asymptomatic dermal or visceral leishmaniasis (VL) constitute a variable and sometimes high
proportion of the naturally exposed population in endemic foci of Leishmania transmission,
ranging from 17 to 91% of incident infections [1–3]. Although xenodiagnosis has shown that
sand flies can acquire infection from asymptomatic dogs in different settings of L. infantum
transmission [4–6], and even from vaccinated dogs [7], the epidemiological impact of asymp-
tomatic infection in the transmission of leishmaniasis is unknown. Parasite persistence and via-
bility have been demonstrated after treatment and clinical resolution of disease [8,9],
supporting the possibility that subclinically infected individuals can accumulate to constitute
an important, unrecognized proportion of the population in endemic foci.
Prospective population-based studies of the natural history of cutaneous leishmaniasis (CL)
in the Pacific coast and North-central regions in Colombia, and the Peruvian Andes showed
that leishmanin skin test (LST) reactivity, and presence of scars compatible with history of CL,
were risk factors for development of new active lesions [1,3,10]. Hence, re-activation of prior
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infection, whether clinically apparent or subclinical, is a potential source of incident disease.
Attention has only recently focused on understanding host, parasite, entomological and epide-
miological determinants of subclinical infection in order to enlighten the development of strat-
egies for disease prevention and control [2].
Consensus criteria for subclinical or asymptomatic human infection are currently unavail-
able primarily due to lack of a means to differentiate immunologically sensitizing exposure to
Leishmania, from persistent infection. Screening for delayed type hypersensitivity response to
Leishmania antigen or in vitro expansion of memory T cells, and serological reactivity (in the
case of asymptomatic VL) are used to define the infected population in endemic settings. How-
ever, immunological reactivity may not be indicative of a persistent infection. Parasitological
demonstration of asymptomatic infection has not been achieved in the context of endemic
exposure to transmission of cutaneous leishmaniasis. Access to parasitological evidence of
infection and quantitative data on infection may allow modeling to make projections of poten-
tial impact [11] and assessment of the epidemiological contribution of persistent subclinical
infection (following asymptomatic infection or successful treatment of symptomatic infection)
to transmission.
Detection of parasite DNA and RNA by molecular methods have demonstrated respec-
tively, the presence and viability of Leishmania after clinical cure [8,9], and in clinically normal
mucosal tissues and peripheral blood monocytes during active disease [12]. To date, the devel-
opment and use of molecular detection methods has been focused on determining the presence
of Leishmania, and quantifying parasite burden in clinical samples. Robust molecular tools for
in-depth analysis of Leishmania genome/transcriptome or genetic diversity such as next gener-
ation sequencing and multilocus microsatellite typing (MLMT) require isolation of, or abun-
dant parasites in tissue samples for adequate performance and in order to obtain informative
results. These requirements have impeded the analysis of samples with low parasite burden
such as those from subclinically infected individuals. PCR-based methods targeting polymor-
phic high copy number coding or non-coding DNA sequences including kDNA, GP63, and
cysteine peptidase b, among others [13], have partially overcome this impediment. However,
standardized side-to-side comparisons between novel and validated methods for diversity anal-
ysis including MLMT or isoenzyme typing have not been conducted.
This investigation sought to demonstrate the presence and viability of Leishmania in blood
and non-invasive mucosal tissue samples from LST positive individuals without active disease
from areas endemic for the transmission of Leishmania species of the Viannia subgenus, and
to design a molecular tool for genetic diversity analysis of Leishmania involved in subclinical
infection. Parasitological demonstration of subclinical infection in individuals residing in foci
of transmission, and the feasibility of molecular characterization of Leishmania populations
found in persistent subclinical infection, provide bases to evaluate the contribution of the
human population in the persistence and dissemination of CL.
Methods
Ethics statement
This study was approved and monitored by the Institutional Review Board for Ethical Conduct
of Research Involving Human Subjects of the Centro Internacional de Entrenamiento e Investi-
gaciones Médicas (CIDEIM) with approval code CIEIH1104, in accordance with national and
international guidelines. All individuals voluntarily participated in the study. Written informed
consent was obtained from each participant over 18 years of age. For children, informed con-
sent was signed by the accompanying parent, and assent was signed by children over 7 years of
age.
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Study design
This descriptive study was conducted in two phases (Fig 1). An initial exploratory phase (Phase
1) was performed to determine the feasibility of molecular detection of persistent subclinical
infection, which evaluated the presence of Leishmania kDNA in blood and mucosal swab sam-
ples from members of five family households of rural areas of Tumaco (Nariño, Colombia),
endemic for infections caused by L. (Viannia) species. Families/households were selected based
on the presence of one household member (index case) with a parasitologically confirmed
prior history of active disease as well as presence of compatible scars and positive leishmanin
skin test reaction (LST), at least one co-habitant with asymptomatic infection based on LST
reactivity in the absence of active or healed lesions, and a minimum of four co-habitants. In the
second phase a larger scale assessment was designed to 1) establish the demonstrable presence
of Leishmania in immunologically defined asymptomatic infection, and 2) to evaluate the per-
sistence, viability and genotypic diversity of Leishmania among asymptomatically infected
individuals and those with subclinical infections following prior symptomatic CL. This study
was conducted in areas of endemic transmission of cutaneous leishmaniasis caused by L.
(Viannia) species in the departments of Nariño and Risaralda in Colombia.
Following LST evaluation, the presence of parasites was assessed by PCR-Southern Blot for
Leishmania kDNA in blood monocytes, aspirates of lesion scars, and swab samples from nasal,
tonsil, and conjunctival mucosa [14]. Parasite viability was determined by qRT-PCR of the
Leishmania 7SLRNA transcript [12], and genetic diversity of Leishmania was assessed by geno-
typing of the conserved region of the kDNA as described below.
Study subjects
184 subjects participated in this study. Phase 1 comprised a total of 30 individuals of which 25
were residents of endemic areas from rural communities of the municipality of Tumaco,
department of Nariño and 5 were residents of non-endemic areas. Study groups were defined
as follows: 1) Individuals with clinical history of CL (n = 5) confirmed by a typical scar of CL
Fig 1. Schematic representation of study phases and study population.
doi:10.1371/journal.pntd.0004273.g001
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[1] and positive LST result, 2) asymptomatic infection (n = 15), defined as residents of an
endemic area of transmission of dermal leishmaniasis, having a positive LST and no evidence
or history of dermal lesions or typical scars; and 3) healthy LST negative participants without
history of leishmaniasis from endemic (n = 5) or non-endemic areas (n = 5) (Fig 1).
Phase 2 included 154 subjects: 103 participants were residents of a rural community in
Pueblo Rico, Risaralda and 51 participants resided in rural communities of the municipality of
Tumaco, department of Nariño. Study groups were as follows: 1) Individuals with clinical his-
tory of CL (n = 116), 2) individuals with asymptomatic infection (n = 17), 3) healthy LST nega-
tive participants from endemic areas (n = 18), and 4) individuals with active parasitologically
confirmed CL (n = 3) that served as positive controls (Fig 1).
Clinical samples
Blood monocytes, lesion/scar aspirates and duplicate swab samples from tonsil, conjunctiva
and nasal mucosa were obtained from the study participants on one occasion. Duplicate sam-
ples were obtained for the purpose of independent RNA and DNA extraction procedures.
Blood monocytes were separated from a 10 mL sample of peripheral blood using 1-Step Mono-
cytes following the manufacturer´s protocol (Accurate Chemical & Scientific Co.). Monocytes
and lesion/scar aspirate samples were stored in TRIzol Reagent at -70°C until processing. RNA
and DNA were extracted from blood monocytes using the AllPrep DNA/RNAMinikit (Qia-
gen). Mucosal swab samples were stored at -20°C until processing, and DNA extracted from
one of the two replicate swabs as previously reported [12,14]. RNA was extracted from the
second swab sample using TRIzol followed by RNA cleanup using the RNeasy extraction Kit
(Qiagen). Purified RNA was treated with DNAse I. All RNA samples were suspended in a final
volume of 35μl of nuclease free water. Quantity and quality of nucleic acids were evaluated
using a NanoDrop2000 spectrophotometer.
Leishmania strains and kDNA sequences
Reference strains and clinical strains isolated from patients with CL were obtained from the
CIDEIM BioBank (S1 Table). All strains were previously typed by monoclonal antibodies and/
or isoenzyme electrophoresis. Promastigotes were maintained at 26°C in RPMI medium sup-
plemented with 10% heat-inactivated foetal bovine serum (Gibco), 1% glutamine, 100 U/ml
penicillin and 100 μg/ml streptomycin. Logarithmic phase promastigotes were harvested by
centrifugation, washed in phosphate-buffered saline (PBS), and solubilized in lysis buffer for
DNA extraction. For the analyses of genetic diversity we also included kDNA sequences
obtained from NCBI Genbank as summarized in S2 Table.
PCR, Southern blot and qRT-PCR
A 242 bp product of the human GAPDH gene was targeted for amplification from all samples
as a quality control procedure, using the primers Fw (5’- CTG GCC CTC TGC CCT CCT ACC
A -3’) and Rv (5’- TTC CAT CCA GCC TGG GGC GAA -3’). L. (Viannia) minicircle kDNA
was amplified from 100ng of DNA samples by PCR using the LV-B1 primers followed by
Southern blot hybridization as previously described [15]. kDNA positive samples were evalu-
ated by real time reverse transcriptase PCR to confirm the viability of parasites and estimate
parasite burden using the Leishmania 7SLRNA transcript as previously described [12] and
using 10μl of the RNA sample. The single copy gene coding for the human TATA Box Binding
protein (TBP) was amplified for quantitation of human nucleated cells. Amplification was per-
formed with the primer set TBP Fw (5’- CAC GAA CCA CGG CAC TGA TT -3’) and TBP Rv
(5`- TTT TCT TGC CAG TCT GGA -3’). PCR efficiency was determined in each individual
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run by inclusion of purified L.(V). panamensis DNA as a positive control. Potential DNA
carry-over or contamination was evaluated by inclusion of blank (water) and negative control
(DNA of PBMCs from a healthy donor) samples. Standard curves for quantitation of parasite
and human nucleated cells were constructed by ten-fold serial dilution of cDNA products
obtained from 1x107 L. (V.) panamensis promastigotes and from the human U-937 promono-
cytic cell line (1 x 107 cells), respectively. Specificity of the qRT-PCR products was assessed by
analysis of the melt peak curve. Parasite burden was calculated by extrapolation to a standard
curve and normalized to the number of human cells based on TBP expression. Real time detec-
tion of amplification products was performed using SYBR Green Master Mix (Applied Biosys-
tems) on a BioRad CFX-96 detection platform. For those kDNA positive samples that were
below the limit of detection of the 7SLRNA qRT-PCR, a maximum likelihood estimate of
0.0001 parasites per reaction (0.00357 parasites per swab) was calculated based on the assump-
tion of 10,000 minicircle kDNA copies and 250 copies of the 7SLRNA transcript per organism
[16,17], and the samples volumes for each assay [18].
kDNA genotyping
Leishmania strains and kDNA positive samples from study participants were processed for
genetic diversity analyses based on sequence comparison of the conserved region of Leish-
maniaminicircle kDNA. A Nested PCR was designed to amplify the conserved block of Leish-
mania kDNA. The external primers LVp1-Fw (5´- GAC ATG CCT CTG GGT AGG GGC
GTT C -3´) and LVp1-Rv (5´- GGG TGG TAC GAT TTT GAC CCT AA -3´) were used for
the first PCR reaction. Internal primers LVp1-Fw and LVp5-Rv (5´- CTG GGA TGC GCG
GCC CAC TAT -3´) were used in the second PCR reaction (S1 Fig). Each 25 μL of the first
PCR reaction mixture contained 0.8 mM of dNTP, 0.04 U/μL high fidelity Platinum Taq poly-
merase (Invitrogen), 2 μL template DNA, 2.2 mMMgCl2, 1 X PCR buffer, and 0.4 nM of
LVp1-Fw and LVp1-Rv primers. The cycling reaction was as follows: 95°C for 5 min, followed
by 35 cycles, each of 1 min at 95°C, 62°C for 30 sec and 72°C for 30 sec, and a final extension of
1 min at 72°C. The products of the first PCR were diluted 1:10 with ultrapure water and 2 μL of
this dilution was used as template for the second PCR, which was performed under the condi-
tions described above using LVp1-Fw and LVp5-Rv primer and set and an annealing tempera-
ture of 59°C. Specificity of the tool was evaluated using total DNA extracted from human
PBMCs obtained from healthy donors. Negative controls included within each reaction were
PCR mix and DNA from human PBMCs. PCR products were separated in 1.3% agarose gels
and products of approximately 180 bp were extracted and purified for the sequencing reaction
using the QIAquick gel extraction kit (Qiagen). An 82bp fragment spanning conserved blocks
1 to 2 from the kDNA was selected for the analysis based on sequence variability in the inter-
block regions. High resolution sequences were obtained by bi-directional Sanger sequencing
(Macrogen-Korea) using LVp1-Fw and LVp5-Rv primers, and sequences edited and analyzed
using BioEdit v7.2.5. Genetic distances were calculated using MEGA 6.0. Selection of the nucle-
otide substitution model was based on MEGA 6.0 outputs for the model that best fitted the
sequence data. Models analyzed included Jukes-Cantor, Hasegawa-Kishino-Yano and
Tamura-Nei among others. Results for model use, based on the full sequence alignment indi-
cated that the Jukes-Cantor model and G distribution best fitted the data. MEGA6 was also
used to construct trees from resulting distance matrices.
Multilocus Microsatellite Typing (MLMT)
DNA was extracted from log-phase promastigotes using DNeasy Blood & Tissue Kit (Qiagen,
USA). Fourteen microsatellite loci distributed in 13 Leishmania chromosomes were amplified
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by PCR, as previously described [19]. The size of the microsatellites was determined by mobil-
ity of the PCR products in 4.5% agarose gels. Genetic distances were estimated using MSA4.05
software and Populations-1.2.32, and neighbor joining and UPGMA trees were constructed
using MEGA6.
Statistical analysis
D'Agostino and Pearson omnibus test [20] was used to test for departures of quantitative data
from normal distributions. For parasite burdens, this was done on log-transformed data. The
MannWhitney U-Test was employed for statistical comparisons. Binomial proportion confi-
dence intervals were calculated with the Wilson method using the 'binom' package in R [21].
Statistical significance was defined as p<0.05. Data were analyzed using Prism 5 software
(GraphPad Software, Inc., La Jolla, CA).
Results
Parasitological demonstration of persistent infection following
asymptomatic infection or clinical resolution of cutaneous leishmaniasis
Amplification of human GAPDH gene in 95% (114 of 120) of the DNA samples obtained from
the 30 participants in the exploratory phase (Phase 1) corroborated the quality of the extracted
DNA. The six GAPDH negative samples corresponded to swab samples from conjunctiva,
reflecting difficulty in obtaining samples of a suitable quality from this potentially informative
tissue. GAPDH negative samples were excluded from further analysis. Four of the 5 individuals
(80%) with prior history of CL (index cases), and 6 of 15 individuals (40%) with asymptomatic
infection had one or more kDNA positive samples (Table 1). kDNA positive samples from the
index case and from one or more asymptomatic cohabitants were found in three of the five
households. A representative blot of samples from members of one household is shown in Fig
2. kDNA positive samples were not found in any of the healthy individuals from either
endemic (n = 5) or non-endemic (n = 5) areas.
Based on the results of the exploratory analyses we proceeded to evaluate samples obtained
from 154 individuals residing in CL endemic communities in Nariño and Risaralda for the
presence of Leishmania kDNA. At least one sample was obtained from each study participant,
however, 27 individuals did not consent to provide blood samples, 9 refused nasal swabs and
25 refused tonsil swabs. Amplification of the human GAPDH gene was achieved in at least one
Table 1. Demonstration of feasibility of detecting asymptomatic infection among household members co-habitating with a prior symptomatic
case using PCR-Southern blot of Leishmania kDNA (Phase1).
At least one kDNA positive sample
Family/
household






1 0/1 0/4 0/0
2 1/1 2/2 0/2
3 1/1 3/4 0/0
4 1/1 1/2 0/2
5 1/1 0/3 0/1
Total (%) 4/5 (80%) 6/15 (40%) 0/5 (0%)
aLST, Leishmanin skin test
b Number of participants with at least one kDNA positive sample (n)/ Total number of participants (N)
doi:10.1371/journal.pntd.0004273.t001
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sample from each of the 154 participants, representing a total of 78% of samples (504 of 647
total samples). Sixty-two percent of GAPDH negative samples (88 of 143) corresponded to
lesion scar aspirates, 33% were from conjunctival swabs and the remaining 5% were from
blood monocytes, nasal and tonsil swabs. The one time sampling of study participants coupled
to PCR of Leishmania kDNA and Southern blot hybridization, revealed parasite persistence in
40% (46/114) of LST+ individuals without active disease, composed of 41 of 97 LST+ partici-
pants with a clinical history of CL and 5 of 17 asymptomatic infected individuals (Table 2).
Nineteen (12%) individuals had more than one kDNA positive sample, for a total of 84 kDNA
positive samples within the study population. Molecular demonstration of the presence of
Leishmania was more frequent among individuals who had clinical evidence of prior symp-
tomatic infection (44%, 51 of 116) than among LST positive asymptomatic infected individuals
(29%, 5 of 17). kDNA positive samples (from blood monocytes, tonsil and nasal mucosa) were
also detected in 3 of 18 skin test negative healthy individuals from endemic areas, and in the
three positive control cases with active disease. Blood monocytes were the most frequently pos-
itive sample for kDNA, being positive in 26% of individuals without active disease, followed by
nasal and tonsil swabs that were positive in 14% of sampled individuals.
Quantification of parasite burden and demonstration of Leishmania
viability
We quantified the parasite burden and assessed the viability of Leishmania among kDNA posi-
tive samples by detection of RNA transcripts of the Leishmania 7SLRNA gene. Transcripts
were amplified from 59% of LST+ individuals in whom Leishmania kDNA had been detected;
from 25 of the 41 participants with clinical history of CL, and from 2 of the 5 asymptomatic
infected individuals. Transcripts were also amplified from 6 of 10 individuals with a history of
CL but with negative or unavailable LST results, and from 2 of the 3 LST- healthy individuals
in the study communities from whom Leishmania kDNA was amplified (Table 2). Amplifica-
tion of the human TATA box binding protein (TBP) gene transcript was successful in 90% of
Fig 2. Detection of Leishmania kDNA in samples from individuals with asymptomatic infection who share a household with a historic symptomatic
case of CL. Leishmaniaminicircle kDNA was detected by PCR amplification and southern blot. Lanes 1–6: Tonsil swab samples; Lanes 7–12: conjunctival
swab samples; Lanes 13–18: nasal mucosa swab samples; Lanes 19–24: blood monocytes. HI: History of CL, H: Healthy, A: Asymptomatic. The arrow
denotes the 700bp band corresponding to the full length amplification product of Leishmaniaminicircle kDNA. The lower band represents an unspecific kDNA
PCR product as confirmed by sequencing.
doi:10.1371/journal.pntd.0004273.g002
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the 84 kDNA positive samples, supporting the quality and reliability of the amplified RNA.
Twenty-eight kDNA positive samples were below the limit of detection of the 7SLRNA
qRT-PCR (10 from blood monocytes and 18 from mucosal swab samples). Parasite loads ran-
ged between 0.2 to 22 parasites per reaction. Absolute parasite loads and those normalized to
the number of human nucleated cells per sample were slightly higher in blood monocytes than
those from mucosal swab samples (Fig 3A–3C). No apparent differences in parasite loads of
different mucosal tissues were observed. The presence of parasite RNA transcripts substantiates
the viability of Leishmania within the sampled tissues and among a high proportion of individ-
uals with subclinical infection.
Comparative analysis of Leishmania diversity by kDNA genotyping and
microsatellite typing
To explore relationships among Leishmania in individuals with subclinical infection and para-
site strains isolated from patients with active disease within the same foci of transmission, we
developed a nested PCR approach targeting a 180bp segment of the conserved region of Leish-
maniaminicircle kDNA spanning blocks 1 to 3. The lower limit of detection of the nested PCR
was 10−3 promastigotes per reaction (Fig 4A). No cross-reactivity with human DNA was
detected (Fig 4B). Amplification products were obtained from Leishmania species pertaining
to both L. (Viannia) and L. (Leishmania) subgenera and a faint amplification product of
~180bp was detected in T. cruzi DNA (Fig 4C). Although multiple sequencing attempts were
performed on T. cruzi amplification products, quality chromatograms were never obtained,
reflecting the low-sensitivity cross reaction due to low homology of the LVp5 primer annealing
site (S1 Fig). Alignment of L. donovani, L. infantum, L.mexicana, L. tarentolae, L. (V.) brazi-
liensis, L. (V.) guyanensis, L. (V.) panamensis and T. cruzi kDNA sequences (S2 Table) showed
that regions between conserved blocks 1 and 2 were polymorphic among species and strains of
the same species (Fig 5).
Table 2. Detection of Leishmania kDNA and 7SLRNA gene transcript in clinical samples from subclinically infected individuals in endemic foci of
CL.
Clinical group Number of participants Participants with at least
one kDNA positive sample.
kDNA+ participants with at
least one 7SLRNA positive
sample.
n/N a %, (95% CI) b n/N c %, (95% CI) d
Clinical history of disease LST + 97 41/97 42%, (33–52) 25/41 61%, (46–74)
LST - 12 6/12 50%, (25–75) 2/6 33%, (10–70)
No LST data 7 4/7 57%, (25–84) 4/4 100%, (51–100)
Subtotal 116 51/116 44%, (35–53) 31/51 61%, (47–73)
Asymptomatic infection (LST +) 17 5/17 29%, (13–53) 2/5 40%, (12–77)
Healthy LST- individuals from endemic area 18 3/18 17%, (6–39) 2/3 67%, (21–94)
Subtotal 151 59/151 39%, (32–47) 35/59 59%, (47–71)
Active CL 3 3/3 100%, (44–100) 3/3 100%, (44–100)
Total 154 62/154 40%, (33–48) 38/62 61%, (49–72)
a Number of participants with kDNA positive sample (n)/ Total number of participants (N)
b % participants with at least one kDNA positive sample and 95% Conﬁdence Interval for proportions of kDNA positivity.
c Number of participants with 7SLRNA positive sample (n) / Total number of participants with kDNA positive samples
d % participants with at least one 7SLRNA positive sample and 95% Conﬁdence Interval for proportions of 7SLRNA positivity.
doi:10.1371/journal.pntd.0004273.t002
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Fig 3. Leishmania viability and parasite burden in kDNA positive samples. Absolute quantification of
Leishmania (A) and human nucleated cells (B) by qRT-PCR amplification of 7SLRNA and TBP transcripts,
respectively, from blood monocytes (n = 33) and mucosal swab samples (n = 37) obtained from tonsil
(triangles), conjunctiva (squares) and nasal mucosa (circles). Data are also shown as relative parasite
burden normalized to the number of human cells per sample (C). Filled black figures represent LST+
individuals with clinical history of CL; open figures, LST+ individuals with asymptomatic infection; and grey
Leishmania Diversity in Subclinical Infections
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To explore the resolution and assess the reliability of the strain grouping achieved by kDNA
genotyping, we performed a comparative analysis against multilocus microsatellite typing
(MLMT). Genetic distances were calculated from MLMT data (S3 Table) and from kDNA
sequences of a panel of 34 L. (V.) panamensis and 9 L. (V.) guyanensis strains isolated
from diverse locations within the Colombian territory (S1 Table). Results showed that both
methods concurred in clustering of strains obtained from individuals with CL in foci of active
figures, healthy LST- individuals from endemic area for CL. p values obtained from two tailed Mann-Whitney
tests are shown.
doi:10.1371/journal.pntd.0004273.g003
Fig 4. Sensitivity and specificity of the nested PCR for Leishmaniaminicircle kDNA.Nested PCR amplification products from serial dilution curves of
DNA from L. V. panamensis promastigotes (A) and human PBMCs (B). The upper panel shows the first amplification product of 700 bp obtained with LVp1
primer sets (external primers) and the bottom panel shows the 180 bp product of the nested PCR obtained with LVp1-LVp5 primer sets (internal primers).
Nested PCR amplification products from reference strains of L.V. panamensis (L.p), L.V. guyanensis (L.g), L.V. braziliensis (L.b), L. infantum (L. inf), L.
amazonensis (L.ama), L.mexicana (L. mex) and T. cruzi (C). C-, negative control—water; PBMCs, DNA from uninfected human PBMCs.
doi:10.1371/journal.pntd.0004273.g004
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transmission during outbreaks of CL, thus delimiting strains by time and location (Fig 6). Nev-
ertheless, subgroups defined by MLMT such as zymodemes 2.2 and 2.3 of L. (V.) panamensis
were not clustered by kDNA genotyping, in line with the higher variability and rate of evolu-
tion of kDNA compared to microsatellite sequences [13,22].
To estimate the best method for data analysis and clustering, we run in parallel Neighbor-
Joining, UPGMA and Maximum Likelihood methods of kDNA sequences. As shown in S2 Fig,
all clustering algorithms provided the same group distribution with the exception of clustering
of database sequences obtained from the L.mexicana complex. Although it is recognized that
bootstrap values are indicators of robustness for definition of the most appropriate clustering
method, bootstrap values were low when using any of the above methods, potentially due the
small sequence size (82bp) and the low overall variability among sequences (where the most
Fig 5. Analysis of Leishmania genetic diversity. An 82bp sequence spanning conserved blocks 1 and 2 from the Leishmaniaminicircle kDNA was used
for multiple sequence alignment. Sequences from five different strains were analyzed for each Leishmania species, and from two T. cruzi strains. Strain
details are summarized in S1 and S2 Tables. CB: Conserved Block.
doi:10.1371/journal.pntd.0004273.g005
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divergent strains—L. (V) panamensis 2363 and L. infantum LLM735—showed 83% sequence
homology). That all of the methods generated similar clustering and that clusters are biologi-
cally concordant, supports their usefulness in these analyses. UPGMA clustering was selected
for data interpretation given that clustering of the subgenera represented more accurately the
Leishmania taxonomy.
Considering the reported variability of kDNA sequences among clinical strains [16,23] and
possible variations introduced during the PCR or sequencing reactions, we assessed the repro-
ducibility of the method by re-amplifying and re-sequencing DNA samples from 13 strains
Fig 6. Genetic diversity analysis usingminicircle kDNA genotyping allows clustering of strains isolated within foci of transmission during
outbreaks of CL.UPGMA trees of distances calculated fromMLMT data (A) and conserved block minicircle kDNA genotyping (B) from a panel of 34 L. V.
panamensis and 9 L. V. guyanensis clinical strains. Figure labels depict the geographical origin of strains within the Colombian territory. Shadowed codes
denote groups of strains isolated from foci of transmission during outbreaks of infection.
doi:10.1371/journal.pntd.0004273.g006
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belonging to different species of the Viannia subgenus obtained from the CIDEIM BioBank.
As shown in S3 Fig, 100% sequence identity was obtained in two independent technical replicas
in sequences from 10 of the 13 strains, and 99% sequence identity (corresponding to a 1bp
change) in sequences from the remaining 3 strains. These results support the reproducibility of
the method for analysis of Leishmania genetic diversity using clinical samples and strains.
kDNA genotyping of samples from individuals with subclinical infection
The intra-species variability of the target sequence and the sensitivity and specificity of the
method for Leishmania kDNA, support the potential of kDNA genotyping for the analysis of
clinical samples with low parasite burden. We attempted to sequence nested PCR amplification
products from 84 kDNA positive samples from 59 individuals. Fifty-four samples from 45 sub-
clinically infected participants were successfully amplified by the nested PCR. However, PCR
products from 33 of these samples, corresponding to 28 individuals with immunological or
molecular evidence of subclinical infection (26 with prior history of CL, 2 with asymptomatic
infection and one from a “healthy” LST- individual in the endemic site) were of sufficient qual-
ity and quantity to provide accurate sequences. kDNA sequences were also obtained from L.
(V.) panamensis strains isolated from the three patients with active CL.
Sequences were analyzed alongside a panel of representative L. (V.) panamensis, L. (V.)
guyanensis and L. (V.) braziliensis strains from diverse geographical origins within the Colom-
bian territory S1 Table), and database sequences from L. donovani and L. infantum as out-
groups (S2 Table). kDNA sequences from individuals with subclinical infection grouped
within the L. (Viannia) cluster (Fig 7). However, the relationship between L. (V.) panamensis
strains currently circulating in the focus of transmission and parasites involved in subclinical
infections that have persisted over many years could not be discerned.
Discussion
Asymptomatic infections are common to all transmissible agents, constituting a variable
segment of the spectrum of outcomes. The frequency of these inapparent infections varies
according to the pathogenicity of the agent and the susceptibility of the exposed population.
Investigations of the incidence of infection based on LST conversion revealed that 90% of inci-
dent infections in a focus of L. (V.) panamensis transmission in the municipality of Tumaco,
Colombia, were asymptomatic [1], whereas only 17% of infections were asymptomatic in a
focus of L. (V.) peruviana transmission in Peru [3]. In the current study, LST reactivity pro-
vided an immunological marker for asymptomatic and subclinical infections, which were
defined respectively as infections that result in skin test conversion but not disease, and persis-
tent infection following clinical resolution of disease. Leishmanin reactivity induced by infec-
tion, whether symptomatic or asymptomatic is typically long-lived and presumably sustained
by antigen exposure. The amplification of kDNA and 7SLRNA transcripts from 40% and 24%
of LST+ individuals, respectively, supports this assumption and demonstrates the technical fea-
sibility of molecular detection of Leishmania in mucosal and blood monocyte samples from
individuals with subclinical infections.
Although the relevance of asymptomatic and subclinical infections to public health is poorly
understood, the detection of Leishmania in the absence of active disease in 40% of LST+ and a
small proportion of LST- residents of endemic foci of L. (Viannia) transmission provides an
indication of the substantial magnitude of the population harboring parasites. Amplification of
Leishmania DNA and RNA from 2 of 18 “healthy” LST negative participants could reflect wan-
ing delayed-type hypersensitivity responses [24] or a lower sensitivity threshold of this
immune-reactivity based method to detect previous parasite exposure. LST negativity in at
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least 12 of 116 participants with prior history of CL is also consistent with either of these sce-
narios. Considering that sampling was conducted only one time and that tissue distribution
Fig 7. Analysis of Leishmania genetic diversity in individuals with infection in the absence of disease. Sequences from the 82bp sequence spanning
conserved blocks 1 and 2 from Leishmaniaminicircle kDNA were analyzed. Shown is a UPGMA tree of the genetic distances of sequences from clinical
samples obtained from study participants with subclinical infection (blue and red triangles) and strains isolated from study participants with active disease
(yellow circles), alongside a panel of 34 L. (V) panamensis, 10 L. (V.) braziliensis, and 9 L. (V) guyanensis clinical strains. Minicircle kDNA sequences
retrieved from NCBI Genbank from 9 L. donovani and 8 L. infantum strains were used as outgroups.
doi:10.1371/journal.pntd.0004273.g007
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and burden of parasites are likely to vary over time as shown with sequential samples of asymp-
tomatic L. infantum infection [25], and with the health status of each individual, the actual
infected population is probably underestimated.
Subclinical infections represent a risk for reactivation and the triggering of pathogenesis.
The recurrent behavior of dermal leishmaniasis in Latin America was clinically recognized in
mucosal disease, long considered a secondary manifestation of prior cutaneous disease [26] or
even prior asymptomatic infection [27]. Direct evidence of re-activation as a cause of recurrent
leishmaniasis was provided by biochemical and genotypic analyses of Leishmania strains iso-
lated from primary lesions and from recurrent or new lesions following complete resolution of
primary lesions [23]. Additionally, activation of CL following local trauma [28] and immuno-
suppression [29–31] in individuals with asymptomatic infection or healed lesions provides evi-
dence for the participation of immunological and inflammatory triggers in the activation/re-
activation of CL. Population-based studies in areas of endemic transmission have identified
both LST reactivity and the presence of scars compatible with history of CL as important risk
factors for development of new incident lesions [1,3,10], underscoring the role of asymptom-
atic and subclinical infection in the epidemiology and natural history of CL. Our results docu-
menting the long-term presence of viable Leishmania in blood monocytes and unaffected
mucosal tissues in individuals with asymptomatic and subclinical infection support the indefi-
nite persistence of Leishmania in the human host.
Through mechanistic mathematical modeling, Miller et.al. have recently shown that a small
proportion of asymptomatically infected individuals (3.2%) with the highest parasitemias in
VL endemic areas in Ethiopia, were responsible for infection of an average 62% of infected
sand fly vectors [11]. Although parasite loads in unaffected mucosal tissues and blood mono-
cytes (0.2 to 22 parasites per reaction, equivalent to 7 to 770 parasites per sample) of individu-
als with subclinical and asymptomatic infection in our study population are relatively low
compared to those with asymptomatic infection in VL endemic areas [11], these are within the
range of parasite loads found in unaffected mucosal tissues in individuals with active CL [12].
Together with lessons learned from investigations of the infectivity of asymptomatic and even
vaccinated dogs for Lu. longipalpis, the principal vector of VL in the Americas, and from
malaria elimination initiatives showing that asymptomatic carriers, in addition to being at risk
of developing disease via reactivation of infection [32] can transmit infection to mosquitos
[33,34], support the possibility that subclinically infected individuals may act as reservoirs for
anthroponotic transmission of L. (Viannia) species, which have traditionally been considered
zoonoses. The importance of understanding the role of subclinical infection in the incidence
and propagation of leishmaniasis has been recently recognized as a priority research area by
the World Health Organization Expert Committee on the Control of the Leishmaniases [35].
A limiting factor in the study of subclinical infection is the technical feasibility for pheno-
typic and genotypic characterization of Leishmania from samples having low parasite burdens.
To address this limitation we developed a strategy for analysis of genetic diversity based on
nested PCR amplification and sequence genotyping of the conserved region of Leishmania
minicircle kDNA. The sensitivity of this strategy allowed Leishmania kDNA sequences to
be obtained from mucosal swab samples and blood monocytes from 28 of individuals with
immunological (LST) or molecular (kDNA detection) evidence of subclinical infection, dem-
onstrating the plausibility of approaching genotypic characterization of Leishmania causing
subclinical infection. Although the sensitivity of nested PCR was comparable to that of kDNA
amplification and detection by southern blot (10−3 promastigotes per reaction), partial degra-
dation of DNA samples after prolonged storage, low concentration of target DNA for the
sequencing reaction and DNA loss during the band purification process could have contrib-
uted to reduced sensitivity of the amplification of clinical samples.
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Regions within the conserved blocks of Leishmania kDNAminicircles were selected as targets
for genetic diversity analysis based on limited yet potentially informative polymorphic character-
istics. The methodology developed revealed diversity among Leishmania causing subclinical
infection in endemic foci of transmission of L. (V.) panamensis, and clustering within the L.
(Viannia) subgenus. Nevertheless, the limited number of active cases (n = 3) and the level of het-
erogeneity in the amplified sequences did not allow relationships to be discerned between strains
isolated from individuals with active disease at the time of the study and Leishmania persisting in
the absence of disease. This could be due to variation in parasite populations during decades of
transmission within the sites, or limitations of the genotyping methodology.
Comparative analysis of kDNA andMLMT genotyping in a panel of strains of L. (Viannia)
species showed clustering of strains isolated from disease outbreaks to be achieved by both meth-
odologies, suggesting that kDNA genotyping could be exploited for future studies of the cycle
and dynamics of transmission in active foci and during disease outbreaks. However, because phe-
notypically distinguishable strains (eg. L. (V.) panamensis strains pertaining to zymodemes 2.2
and 2.3) clustered by MLMT but not kDNA typing, micro-heterogeneity of kDNA sequences
could impede the discernment of relationships among closely related parasites [36,37]. This out-
come illustrates some of the limitations of kDNA genotyping, which include analysis of a single
target sequence and the sequence length. Multi-target sequence analysis of polymorphic and high
copy number sequences such as miniexon, Cytochrome B, GP63 or Cysteine proteinase B genes
[38], and improved sensitivity for minicircle kDNA amplification could optimize the robustness
of this approach to accessing subclinical infection and the parasites involved.
Our results provide parasitological confirmation of persistent infection in the absence of
disease among residents of endemic areas of CL and a methodological approach to investigate
the epidemiology and public health impact of subclinical infections. The novel exploitation of
kDNA genotyping establishes proof-of-principle of the feasibility of genetic diversity analysis
in parasite populations previously inaccessible and unexplored, and provides bases for more
robust analyses of the relationships among these parasite populations.
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